Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Cancer Lett. 2011 Oct 12;315(1):48–58. doi: 10.1016/j.canlet.2011.10.007

Table II.

CK2αα′ mRNA Steady-State Expression Levels in TBG-siCK2 Treated Cells

Cell Line Treatment (10 μM) Time Point (h) CK2α CK2α′
PC3-LN4 TBG-siCK2 24 h 0.641 ± 0.102 0.868 ± 0.055
PC3-LN4 TBG-siCK2 48 h 0.672 ± 0.085 0.874 ± 0.025
PC3-LN4 TBG-Sugar 24 & 48 h 1 1
BPH-1 TBG-siCK2 72 h 0.828 ± .0162 1.115 ± 0.031
BPH-1 TBG-Sugar 72 h 1 1

All values normalized to HPRT mRNA expression and expressed relative to TBG-Sugar control treatment.